What's driving Neurovascular embolization devices Market ; Eminent Players - Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A.

Neurovascular embolization devices are majorly adopted by hospitals owing to the requirement of high-end technological devices for the purpose of visualization, navigation, precision and complex nature of the surgery. The outpatient centers segment is projected to grow at a CAGR of 4.8% over the forecast period due to increasing demand for minimally invasive surgeries.

With significant presence of key players and high healthcare expenditure, North America is projected to be the dominant regional market for neurovascular embolization devices over the forecast period. Asia Pacific neurovascular embolization devices market is projected to grow at a CAGR of 5.2% due to growing awareness regarding brain aneurysms and other neurovascular diseases as well as significant presence of key manufacturers.

Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/25969

The report tracks some of the key companies operating in the neurovascular embolization devices market, including Integra LifeSciences Corporation, Medtronic plc, Resonetics Llc., Acandis GmbH, B. Braun Melsungen AG., Stryker Corporation, Penumbra Inc., Balt Extrusion S.A., Terumo Corporation, and Johnson and Johnson Services, Inc.

The increasing awareness regarding neurovascular disease, and technological advancements in the diagnostic techniques are expected to propel the demand for neurovascular embolization devices over the forecast period. As per the latest research by the company, the global neurovascular embolization devices market is expected to account for more than US$ 1,733.1 Mn, in terms of value, by 2028 end. The report on neurovascular embolization devices market further projects significant growth potential with average year-on-year growth rate estimated at 4.4% through 2028. This elevation in the growth graph of neurovascular embolization devices market is attributed to increasing demand for minimally invasive neurosurgical procedure for better patient outcomes.

It is claimed by the Brain Aneurysm Foundation that around 6 million people in the U.S. suffer from brain aneurysms, which is expected to fuel the adoption minimally invasive neurovascular procedure. More than 500,000 people worldwide die due to stroke and other disorders associated with cerebral aneurysms, which is also increasing the demand for neurovascular embolization devices. Intracranial aneurysm is prevalent in individuals younger than 60 years, as half out of the total mortality rate due to brain aneurysms comprises share of young individuals below age 50.

It is been found by the Brain Aneurysm Foundation that about 15% of individuals possessing aneurysms in the neurovascular tract are very likely to have more than one aneurysm. This factor further increases the demand for neurovascular embolization devices from the individuals suffering from cerebral aneurysms. Neurovascular aneurysms if not treated can result in severe consequences of neurological defects and permanent impairment of cognitive functions in the absence of neurovascular embolization devices. The observations of these outcomes from brain aneurysms is also projected to fuel the demand for neurovascular embolization devices over the forecast period.

Request For Methodology @ https://www.persistencemarketresearch.com/methodology/25969

The company has segmented the global neurovascular embolization devices market based on product type, end user and region. In terms of revenue, the embolization devices product type segment of the neurovascular embolization devices market is expected to hold significant share and grow at a high CAGR of 4.9% in the global neurovascular embolization devices market over the forecast period.

Flow diversion stents segment in the neurovascular embolization devices market is also expected to grow at a significant CAGR owing to the low associated risks and their growing adoption by the end users. Aneurysm clips segment in the neurovascular embolization devices market is estimated to contribute 2.4% market share in the terms of revenue. These devices have witness significant decrease in demand due to invasive nature of the treatment.

Table of Contents

13. Competition Landscape

13.1. Competition Dashboard
13.2. Company Deep Dive
13.2.1. Medtronic plc
13.2.1.1. Overview
13.2.1.2. Product and End Users Portfolio
13.2.1.3. Production Footprint
13.2.1.4. Sales Footprint
13.2.1.5. Channel Footprint
13.2.1.6. Strategy
13.2.1.6.1. Marketing Strategy
13.2.1.6.2. Product Strategy
13.2.1.6.3. Channel Strategy
13.2.2. Stryker Corporation
13.2.3. Terumo Corporation
13.2.4. Johnson & Johnson Services, Inc.
13.2.5. Penumbra Inc.
13.2.6. Balt Extrusion S.A
13.2.7. B. Braun Melsungen AG.
13.2.8. Integra LifeSciences Corporation
13.2.9. Resonetics Llc
13.2.10. Acandis GmbH

14. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028 By Region

14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) Analysis By Region
14.2.1. North America
14.2.2. Latin America
14.2.3. Europe
14.2.4. APAC
14.2.5. Middle East and Africa
14.3. Market Size (US$ Mn) Forecast By Region
14.4. Market Attractiveness Analysis By Region

15. Global Neurovascular Embolization Devices Market Analysis 2013–2017 and Forecast 2018–2028, By Product Type

15.1. Introduction/Key Finding
15.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017
15.2.1. Embolization Coils
15.2.2. Liquid Embolic Systems
15.2.3. Flow Diversion Stents
15.2.4. Aneurysm Clips
15.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
15.4. Market Attractiveness Analysis By Product Type

Buy Now@ https://www.persistencemarketresearch.com/checkout/25969

ABOUT US:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.